Mirtazapine vs. placebo in posttraumatic stress disorder: A pilot trial

Biological Psychiatry

Volumn 53, Issue 2, 2003, Pages 188-191

  Davidson, Jonathan R T ^a   Weisler, Richard H ^a,b   Butterfield, Marian I ^a,c   Casat, Charles D ^a,d   Connor, Kathryn M ^a   Barnett, Stewart ^e   Van Meter, Susan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Private Practice   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d CAROLINAS MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Efficacy; Mirtazapine; Posttraumatic stress disorder

Indexed keywords

MIRTAZAPINE; PLACEBO;

ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; HUMAN; INTERVIEW; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TIME; TREATMENT OUTCOME;

EID: 0037439549     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01411-7     Document Type: Article

References (22)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed: 1994; American Psychiatric Press, Washington, DC.
2. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1082-1152.
3. Brady K.T., Pearlstein T., Asnis G.M., Baker D., Rothbaum B., Sikes C.R., Farfel G.M. Efficacy and safety of sertraline treatment of posttraumatic stress disorder A randomized controlled trial . JAMA. 283:2000;1837-1844.
4. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed: 1988; Lawrence Erlbaum and Associates, Hillsdale, NJ.
5. Connor K.M., Davidson J.R. SPRINT A brief global assessment of post-traumatic stress disorder . Int Clin Psychopharmacol. 16:2001;1-5.
6. Connor K.M., Davidson J.R., Churchill L.E. Adverse events associated with kava. CNS Spectrums. 6:2001;848-853.
7. Connor K.M., Davidson J.R., Weisler R.H., Ahearn E. A pilot study of mirtazapine in post-traumatic stress disorder. Int Clin Psychopharmacol. 13:1999;111-113.
8. Connor K.M., Sutherland S.M., Tupler L.A., Malik M.A., Davidson J.R. Fluoxetine in post-traumatic stress disorder. Br J Psychiatry. 175:1999;17-22.
9. Davidson J.R., Book S.W., Colket J.T., Tupler L.A., Roth S., David D. Assessment of a new self-rating scale for posttraumatic stress disorder. Psychological Med. 27:1997;153-160.
10. Davidson J.R., Malik M.A., Travers J. Structured interview for PTSD (SIP) Psychometric validation for DSM-IV criteria . Dep Anxiety. 5:1997;127-129.
11. Davidson J.R., Rothbaum B.O., van der Kolk B.A., Sikes C.R., Farfel G.M. Multicenter, double-blind, comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 58:2001;485-492.
12. Falkai P. Mirtazapine Other indications . J Clin Psychiatry. 60:(suppl 17):1999;36-40.
13. Marshall R.D., Beebe K.L., Oldham M., Zaninelli R. Efficacy and safety of paroxetine treatment of chronic PTSD A fixed dosage placebo-controlled study . Am J Psychiatry. 158:2001;1982-1988.
14. McGahuey C.A., Gelenberg A.J., Lankes C.A., Moreno F.A., Delgado P.L. The Arizona Sexual Experiences Scale (ASEX) Reliability and validity . J Sex Marital Ther. 26:2000;25-40.
15. Nutt D.J. Care of depressed patients with anxiety symptoms. J Clin Psychiatry. 60:(suppl 17):1999;23-27.
16. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E. The Mini-International Neuropsychiatric Interview (MINI) The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 . J Clin Psychiatry. 59:(suppl 20):1998;22-57.
17. Thase M. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry. 60:(suppl 17):1999;28-31.
18. Thompson C. Mirtazapine vs selective serotonin reuptake inhibitors . J Clin Psychiatry. 60:(suppl 17):1999;18-22.
19. Tucker P., Zaninelli R., Yehuda R., Ruggiero L., Dillingham K., Pitts C.D. Paroxetine in the treatment of chronic posttraumatic stress disorder Results of a placebo-controlled, flexible-dosage trial . J Clin Psychiatry. 62:2001;860-868.
20. van der Kolk B.A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 55:1994;517-522.
21. Westenberg H.G.M. Pharmacology of antidepressants Selectivity or multiplicity? J Clin Psychiatry. 60:(suppl 17):1999;4-9.
22. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scand. 67:1983;361-370.